SEC Form D · Amendment · filed January 13, 2025
Cambrian BioPharma Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (15)
Maryanna G. Saenko · New York, NYDirectorJames G. Peyer · New York, NYExec · DirectorChristian G. Angermayer · New York, NYDirectorBrenton G. Saunders · New York, NYDirectorPaul G. Farr · New York, NYDirectorBrenton G. Saunders · New York, NYDirectorAnton Zietsman · Santa Monica, CADirectorTravis Kell · Santa Monica, CAExec · DirectorAron Shapiro · Encinitas, CADirectorPaul G. Farr · New York, NYDirectorJeffery C. Schneider · MOORESTOWN, NJExec · DirectorRobert S. Newell · Las Vegas, NVDirectorMatthew Gaylord · Waltham, MADirectorJohn D. Lerosen · PACIFIC PALISADES, CADirectorBrian D. Martin · PACIFIC PALISADES, CADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗